Medigo GmbH

Medigo GmbH is a Third-Party Administrator (TPA) that specializes in providing healthcare administration services to insurance companies. Their focus is on enhancing the patient experience and streamlining medical claims processes on a global scale. Founded in 2013 in Berlin, Germany, Medigo GmbH operates as a health insurance service provider, focusing on medical claims management and related services. The company was established by Ieva Soblickaite, Lakshya Sinha, Pawel Cebula, and Sivan Dinman.

The CEO is Aurélien Guèye. Medigo has raised a total of EUR 3. 35 mn, with the latest funding round occurring in September 2016 from investors including Accel, Atlantic Labs, and CL Ventures, bringing their current valuation to EUR 25. 34 mn.

Medigo operates as a Third-Party Administrator (TPA) primarily catering to the health insurance industry. Their core offerings include medical claims management, cost containment, Second Medical Opinion services, telemedicine, and medical concierge support. Medigo’s innovative technology facilitates cashless access to an extensive network of healthcare providers across over 100 countries, ensuring efficient management of medical claims and high-quality care. Their multilingual support team enhances customer service by providing assistance in over 15 languages, supporting clients in markets such as Asia, Europe, and the Middle East.

Medigo's revenue model is built around B2B transactions with insurance companies that engage the firm for its specialized healthcare administration services. Clients access Medigo's comprehensive medical claims management and cost containment solutions, paying based on their specific needs through a subscription or fee-for-service model. This structure enables clients to manage healthcare costs effectively while maintaining high-quality service, supported by proprietary claims management software and cashless payment solutions essential to their operational success. Medigo GmbH plans to utilize its recent funding of EUR 3.

35 mn, raised in September 2016, to expand its product offerings and enter new markets. The company aims to launch additional telemedicine services by late 2024 and is targeting expansion into the North American and Asian markets by 2025. These initiatives are designed to enhance the company's service portfolio and reach a broader client base in the healthcare sector.